Abstract
AbstractMachine learning protein structure prediction, such as RosettaFold and AlphaFold2, have impacted the structural biology field, raising a fair amount of discussion around its potential role in drug discovery. While we find some preliminary studies addressing the usage of these models in virtual screening, none of them focus on the prospect of hit-finding in a real-world virtual screen with a target with low sequence identity. In order to address this, we have developed an AlphaFiold2 version where we exclude all structural templates with more than 30% sequence identity. In a previous study, we used those models in conjunction with state of the art free energy perturbation methods. In this work we focus on using them in rigid receptor ligand docking. Our results indicate that using out-of-the-box Alphafold2 models is not an ideal scenario; one might think in including some post processing modeling to drive the binding site into a more realistic holo target model.
Publisher
Cold Spring Harbor Laboratory
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献